思密达等三联治疗反流性食管炎疗效观察  

Clinical observation of three sorts of medicines insluding smecta on reflux esophagitis patients

作　　者：蔡玉辉[1] 

机构地区：[1]江苏省海门市第二人民医院内科,226121

出　　处：《现代中西医结合杂志》2002年第3期196-197,共2页Modern Journal of Integrated Traditional Chinese and Western Medicine

摘　　要：目的 :观察思密达、西沙比利、雷尼替丁联合治疗反流性食管炎的疗效。方法 :将 74例反流性食管炎患者随机分为治疗组及对照组各 37例。治疗组给予思密达、西沙比利、雷尼替丁联合治疗 ;对照组给予西沙比利、雷尼替丁治疗。比较两组疗效。结果 :治疗组治愈 32例 ,显效 3例 ,有效 2例 ,无效 0例 ;对照组治愈 9例 ,显效 5例 ,有效 10例 ,无效 3例。经统计学处理 ,治疗组疗效优于对照组 ,有显著性差异 ( P<0 .0 1)。结论 :思密达、西沙比利、雷尼替丁联合治疗反流性食管炎疗效显著 ,且明显优于西沙比利合雷尼替丁联合治疗的疗效。Objective: It is to observe the effect of smecta, cisapride and ranitidine on reflux esophagitis(RE). Methods: Seventy-four patients with RE were randomly divided into two groups. Thirty-seven patients in treatment group were treated with smecta, cisapride and raniidine. Thirty-seven patients in control group were treated with cisapride and ranitidine. The effects of the two groups were compared. Results: In treatment group, 32 patients were cured, 3 with significant improvement, 2 with improvement and none with no change. In control group, 9 patients were cured, 15 with significant improvement, 10 with improvement and 3 with no change. The effective rate of treatment group was significantly higher than that of control group( P <0.01). Conclusion: The effect of smecta, cisapride and ranitidine on patients with RE is significant and better than that of control group.

关 键 词：思密达 西沙比利 雷尼替丁 反流性食管炎 药物疗法 疗效 

分 类 号：R571[医药卫生—消化系统] R975[医药卫生—内科学]